Our Areas of Focus
We are advancing a strong group of innovative clinical assets in ophthalmology, neurology & psychiatry. These drug candidates provide us a risk-balanced portfolio in a mix of major disease states characterized by high unmet patient needs.
-306.jpg)
-557.jpg)
